SEL120: a promising CDK8 kinase inhibitor
A novel CDK8 inhibitor has been developed by scientists at…
A novel CDK8 inhibitor has been developed by scientists at Ryvu Therapeutics. Dr Krzysztof Brzozka showcases this molecule and explains the R&D behind it.